5,6-Dihydromidazolam is a reduced derivative of the benzodiazepine midazolam, characterized by a chiral center and a molecular structure that includes chlorine and fluorine substituents. It is primarily used as a pharmaceutical impurity reference standard in analytical testing and quality control for midazolam-related substances.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 59468-07-4
8-Chloro-6-(o-fluorophenyl)-1-methyl-4H-imidazo(1,5-a)(1,4)benzodiazepine-3-carboxylic acid
pharmaceutical intermediate
Reduced reduced midazolam
pharmaceutical intermediate
2-Aminomethyl-7-chloro-2,3-dihydro-5-(2-fluorophenyl)-1H-1,4-benzodiazepine Dimaleate
pharmaceutical intermediate
3-Chloro-2-nitroaniline
pharmaceutical intermediate
N-Nitroso Midazolam EP Impurity A
pharmaceutical intermediate
8-chloro-6-(2-fluorophenyl)-1-methyl-5,6-dihydro-4H-imidazo[1,5-a][1,4]benzodiazepine
HMQYFIKOHHSETE-UHFFFAOYSA-N
CC1=NC=C2N1C3=C(C=C(C=C3)Cl)C(NC2)C4=CC=CC=C4F